{"id":"https://openalex.org/W1998735190","doi":"https://doi.org/10.1111/dom.12102","title":"Alogliptin versus glipizide monotherapy in elderly type 2 diabetes mellitus patients with mild hyperglycaemia: a prospective, double\u2010blind, randomized, 1\u2010year study","display_name":"Alogliptin versus glipizide monotherapy in elderly type 2 diabetes mellitus patients with mild hyperglycaemia: a prospective, double\u2010blind, randomized, 1\u2010year study","alternate_titles":[],"publication_year":2013,"publication_date":"2013-04-18","ids":{"openalex":"https://openalex.org/W1998735190","doi":"https://doi.org/10.1111/dom.12102","mag":"1998735190","pmid":"https://pubmed.ncbi.nlm.nih.gov/23531118"},"language":"en","primary_location":{"id":"doi:10.1111/dom.12102","doi":"https://doi.org/10.1111/dom.12102","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.12102","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1998735190"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045489578","display_name":"Julio Rosenstock","orcid":"https://orcid.org/0000-0001-8324-3275","observed_orcids":["https://orcid.org/0000-0001-8324-3275"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J. Rosenstock","raw_affiliation_strings":["Dallas Diabetes and Endocrine Center at Medical City Dallas TX USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dallas Diabetes and Endocrine Center at Medical City Dallas TX USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Wilson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Wilson","raw_affiliation_strings":["Takeda Global Research & Development Center, Inc. Deerfield IL USA","Takeda Global Research and Development Center, Inc, Deerfield, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Global Research & Development Center, Inc. Deerfield IL USA","institution_ids":["https://openalex.org/I4210140176"]},{"raw_affiliation_string":"Takeda Global Research and Development Center, Inc, Deerfield, IL, USA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011829580","display_name":"Penny R. Fleck","orcid":"https://orcid.org/0000-0003-3597-975X","observed_orcids":["https://orcid.org/0000-0003-3597-975X"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Fleck","raw_affiliation_strings":["Takeda Global Research & Development Center, Inc. Deerfield IL USA","Takeda Global Research and Development Center, Inc, Deerfield, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Global Research & Development Center, Inc. Deerfield IL USA","institution_ids":["https://openalex.org/I4210140176"]},{"raw_affiliation_string":"Takeda Global Research and Development Center, Inc, Deerfield, IL, USA","institution_ids":["https://openalex.org/I4210140176"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5045489578"],"corresponding_institution_ids":[],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":8.0173,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.98233253,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"15","issue":"10","first_page":"906","last_page":"914"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alogliptin","display_name":"alogliptin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/glipizide","display_name":"glipizide","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9940000176429749},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9940000176429749},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.847000002861023},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.8820000290870667},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.593999981880188},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8240000009536743},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9430000185966492},{"id":"https://openalex.org/keywords/weight-change","display_name":"weight change","score":0.7739999890327454},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.871999979019165}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9764177799224854},{"id":"https://openalex.org/C2780012697","wikidata":"https://www.wikidata.org/wiki/Q4734170","display_name":"Alogliptin","level":5,"score":0.9551243782043457},{"id":"https://openalex.org/C2779555806","wikidata":"https://www.wikidata.org/wiki/Q3108899","display_name":"Glipizide","level":3,"score":0.679000735282898},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.6361175775527954},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6245142817497253},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.6099165081977844},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5512283444404602},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5313547253608704},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.46789538860321045},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.42096126079559326},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.27951034903526306},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.21092340350151062},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.09577757120132446},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D004244","descriptor_name":"Dizziness","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005913","descriptor_name":"Glipizide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005913","descriptor_name":"Glipizide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006261","descriptor_name":"Headache","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015430","descriptor_name":"Weight Gain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/dom.12102","doi":"https://doi.org/10.1111/dom.12102","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.12102","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:23531118","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23531118","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320308576","display_name":"Takeda Pharmaceuticals North America","ror":"https://ror.org/03bygaq51"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W63541796","https://openalex.org/W1569365382","https://openalex.org/W1755374604","https://openalex.org/W1967880623","https://openalex.org/W1982871734","https://openalex.org/W2031542147","https://openalex.org/W2039443663","https://openalex.org/W2039502953","https://openalex.org/W2058831278","https://openalex.org/W2067180430","https://openalex.org/W2073416536","https://openalex.org/W2074343527","https://openalex.org/W2082354988","https://openalex.org/W2087025850","https://openalex.org/W2097995302","https://openalex.org/W2107562831","https://openalex.org/W2111876001","https://openalex.org/W2120202508","https://openalex.org/W2140047096","https://openalex.org/W2143910895","https://openalex.org/W2145583809","https://openalex.org/W2153449155","https://openalex.org/W2333089687"],"related_works":["https://openalex.org/W2140205911","https://openalex.org/W1569365382","https://openalex.org/W2344658675","https://openalex.org/W1981478931","https://openalex.org/W2086842286","https://openalex.org/W2592996796","https://openalex.org/W2353007761","https://openalex.org/W1968736342","https://openalex.org/W2234801053"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"prospectively":[2],"evaluate":[3],"the":[4,87,113,116,148],"efficacy":[5],"and":[6,105,151,155,175,247],"safety":[7],"of":[8,24,34,96,115,120,229,239,245],"alogliptin":[9,64,101,121,154,172],"versus":[10,208],"glipizide":[11,68,108,123,184,209,230],"in":[12,204,231],"elderly":[13,35,232],"patients":[14,37,145,194,233],"with":[15,41,100,107,153,157,178,199,234,241],"type":[16],"2":[17],"diabetes":[18],"mellitus":[19],"(T2DM)":[20],"over":[21,236],"1":[22,237],"year":[23,238],"treatment.":[25],"METHODS:":[26],"This":[27],"was":[28,173],"a":[29,94],"randomized,":[30],"double-blind,":[31],"active-controlled":[32],"study":[33],"T2DM":[36,235],"(aged":[38],"65-90":[39],"years)":[40],"mild":[42],"hyperglycaemia":[43],"on":[44],"diet/exercise":[45],"therapy":[46],"alone":[47],"[glycosylated":[48],"haemoglobin":[49],"(HbA1c)":[50],"6.5-9.0%]":[51],"or":[52,67],"plus":[53],"oral":[54],"antidiabetic":[55],"monotherapy":[56,222],"(HbA1c":[57],"6.5-8.0%).":[58],"Patients":[59],"were":[60,79,98],"randomized":[61],"to":[62,72,122,227],"once-daily":[63],"25":[65],"mg":[66,70],"5":[69],"titrated":[71],"10":[73],"mg,":[74],"if":[75],"needed.":[76],"Hypoglycaemic":[77],"episodes":[78,182],"systematically":[80],"captured":[81],"under":[82],"predefined":[83],"criteria.":[84],"RESULTS:":[85],"In":[86],"primary":[88],"analysis,":[89],"HbA1c":[90,141],"mean":[91,127,162],"changes":[92,207],"from":[93],"baseline":[95],"7.5%":[97],"-0.14%":[99],"(n":[102,109],"=":[103,110,129,164],"222)":[104],"-0.09%":[106],"219)":[111],"at":[112,214],"end":[114],"study,":[117],"demonstrating":[118],"non-inferiority":[119,158],"[least":[124],"squares":[125],"(LS)":[126],"difference":[128,163],"-0.05%;":[130],"one-sided":[131,166],"97.5%":[132,167],"confidence":[133],"interval":[134],"(CI):":[135],"-\u221e,":[136,169],"0.13%].":[137],"More":[138],"clinically":[139],"relevant":[140],"reductions":[142],"occurred":[143],"among":[144],"who":[146],"completed":[147],"study:":[149],"-0.42":[150],"-0.33%":[152],"glipizide,":[156],"again":[159],"confirmed":[160],"(LS":[161],"-0.09%;":[165],"CI:":[168],"0.07%).":[170],"Overall,":[171],"safe":[174],"well":[176],"tolerated,":[177],"notably":[179],"fewer":[180],"hypoglycaemic":[181],"than":[183],"[5.4%":[185],"(31":[186],"episodes)":[187],"vs.":[188,211],"26.0%":[189],"(232":[190],"episodes),":[191],"respectively];":[192],"three":[193],"experienced":[195],"severe":[196],"hypoglycaemia,":[197],"all":[198],"glipizide.":[200],"Alogliptin":[201,221],"also":[202],"resulted":[203],"favourable":[205],"weight":[206,249],"(-0.62":[210],"0.60":[212],"kg":[213],"week":[215],"52;":[216],"p":[217],"<":[218],"0.001).":[219],"CONCLUSIONS:":[220],"maintained":[223],"glycaemic":[224],"control":[225],"comparable":[226],"that":[228],"treatment,":[240],"substantially":[242],"lower":[243],"risk":[244],"hypoglycaemia":[246],"without":[248],"gain.":[250]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1998735190","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":21},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
